Prognostic categories for amyotrophic lateral sclerosis

References

• Johnston CA, Stanton BR, Turner MR, Gray R, Blunt AH, Butt D, . Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London. J Neurol. 2006;253:1642–3.
   PubMed Web of Science ®Google Scholar
• The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989. J Neurol Neurosurg Psychiatry. 1992;55:536–41.
   PubMed Web of Science ®Google Scholar
• Kasarkis EJ, Dominic K, Oddone EZ. The National Registry of Veterans with Amyotrophic Lateral Sclerosis: Department of Veterans Affairs Cooperative Studies Program (CSP) #500a. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5 (Suppl 1):129–32.
   PubMedGoogle Scholar
• Miller RG, , Anderson FA JrBradley WG, Brooks BR, Mitsumoto H, Munsat TL, . The ALS patient care database: goals, design, and early results. ALS C.A.R.E. Study Group. Neurology. 2000;54:53–7.
   PubMed Web of Science ®Google Scholar
• Millul A, Beghi E, Logroscino G, Micheli A, Vitelli E, Zardi A. Survival of patients with amyotrophic lateral sclerosis in a population based registry. Neuroepidemiology. 2005;25:114–9.
   PubMed Web of Science ®Google Scholar
• Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995–1997: a population based study. Neurology. 1999;52:504–9.
   PubMed Web of Science ®Google Scholar
• Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain. 1995;118:707–19.
   PubMed Web of Science ®Google Scholar
• Turner MR, Bakker M, Sham P, Shaw CE, Leigh PN, Al-Chalabi A. Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;3:15–21.
   PubMed Web of Science ®Google Scholar
• Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, . Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2008;10:1–14.
   Google Scholar
• Lai EC, Felice KJ, Festoff BW, Gawel MJ, Gelinas DF, Kratz R, . Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group. Neurology. 1997;49:1621–30.
   PubMed Web of Science ®Google Scholar
• Borasio GD, Robberecht W, Leigh PN, Emile J, Guiloff RJ, Jerusalem F, . A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group. Neurology. 1998;51:583–6.
   PubMed Web of Science ®Google Scholar
• Branched-chain amino acids and amyotrophic lateral sclerosis: a treatment failure? The Italian ALS Study Group. Neurology. 1993;43:2466–70.
   PubMedGoogle Scholar
• Armon C, Graves MC, Moses D, Forte DK, Sepulveda L, Darby SM, . Linear estimates of disease progression predict survival in patients with amyotrophic lateral sclerosis. Muscle & Nerve. 2000;23:874–82.
   PubMed Web of Science ®Google Scholar
• Tysnes OB, Vollset SE, Larsen JP, Aarli JA. Prognostic factors and survival in amyotrophic lateral sclerosis. Neuroepidemiology. 1994;13:226–35.
   PubMed Web of Science ®Google Scholar
• Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet. 1996;347:1425–31.
   PubMed Web of Science ®Google Scholar
• Abhinav K, Stanton B, Johnston C, Hardstaff J, Orrell RW, Howard R, . Amyotrophic lateral sclerosis in south-east England: a population based study. The South-East England Register for Amyotrophic Lateral Sclerosis (SEALS Registry). Neuroepidemiology. 2007;29:44–8.
   PubMed Web of Science ®Google Scholar
• Scott KM, Abhinav K, Stanton BR, Johnston C, Turner MR, Ampong MA, . Geographical clustering of amyotrophic lateral sclerosis in south-east England: a population study. Neuroepidemiology. 2009;32:81–8.
   PubMed Web of Science ®Google Scholar
• Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial ‘Clinical limits of amyotrophic lateral sclerosis’ workshop contributors. J Neurol Sci. 1994;124 (Suppl):96–107.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Wijesekera LC, Mathers S, Talman P, Galtrey C, Parkinson MH, Ganesalingam J, . Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology. 2009;72:1087–94.
   PubMed Web of Science ®Google Scholar
• Manjaly ZR, Scott KM, Abhinav K, Wijesekera L, Ganesalingam J, Goldstein LH, . The sex ratio in amyotrophic lateral sclerosis: a population based study. Amyotroph Lateral Scler. 2010;11:439–42.
   PubMed Web of Science ®Google Scholar
• Jablecki CK, Berry C, Leach J. Survival prediction in amyotrophic lateral sclerosis. Muscle Nerve. 1989;12: 833–41.
   PubMed Web of Science ®Google Scholar
• Christensen PB, Hojer-Pedersen E, Jensen NB. Survival of patients with amyotrophic lateral sclerosis in two Danish counties. Neurology. 1990;40:600–4.
   PubMed Web of Science ®Google Scholar
• Chancellor AM, Slattery JM, Fraser H, Swingler RJ, Holloway SM, Warlow CP. The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register. J Neurol. 1993;240: 339–46.
   PubMed Web of Science ®Google Scholar
• Tysnes OB, Vollset SE, Larsen JP, Aarli JA. Prognostic factors and survival in amyotrophic lateral sclerosis. Neuroepidemiology. 1994;13:226–35.
   PubMed Web of Science ®Google Scholar
• Lee JR, Annegers JF, Appel SH. Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. J Neurol Sci. 1995;132:207–15.
   PubMed Web of Science ®Google Scholar
• Louwerse ES, Visser CE, Bossuyt PM, Weverling GJ. Amyotrophic lateral sclerosis: mortality risk during the course of the disease and prognostic factors. The Netherlands ALS Consortium. J Neurol Sci. 1997;152 (Suppl 1):S10–7.
   PubMed Web of Science ®Google Scholar
• Stambler N, Charatan M, Cedarbaum JM. Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology. 1998;50:66–72.
   PubMed Web of Science ®Google Scholar
• http://www.patientslikeme.com/conditions/9-als-amyotrophic-lateral-sclerosis
   Google Scholar